Northwest Biotherapeutics Inc (NWBO): EPS (Basic)
-$0.04
Year ended 2025-12-31
| Period ended | EPS (Basic) | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$0.04 | n/m | 2026-04-15, From 2025-01-01 |
| 2024-12-31 | -$0.07 | n/m | 2026-04-15, From 2024-01-01 |
| 2023-12-31 | -$0.06 | n/m | 2025-03-31, From 2023-01-01 |
| 2022-12-31 | -$0.10 | n/m | 2024-03-05, From 2022-01-01 |
| 2021-12-31 | $0.21 | n/m | 2024-03-05, From 2021-01-01 |
| 2020-12-31 | -$0.73 | n/m | 2023-02-28, From 2020-01-01 |
| 2019-12-31 | -$0.04 | n/a | 2022-03-01, From 2019-01-01 |
| No annual figure between 2011-12-31 and 2019-12-31. | |||
| 2011-12-31 | -$0.35 | n/m | 2012-04-13, From 2011-01-01 |
| 2010-12-31 | -$0.41 | n/a | 2012-04-13, From 2010-01-01 |
EPS (Basic) at similar companies
| Company | Year ended | EPS (Basic) | Change YoY |
|---|---|---|---|
| Northwest Biotherapeutics Inc (NWBO) | 2025-12-31 | -$0.04 | n/m |
| Avenue Therapeutics, Inc. (ATXI) | 2025-12-31 | -$0.93 | n/m |
| NRX Pharmaceuticals, Inc. (NRXP) | 2025-12-31 | -$1.34 | n/m |
| IGC Pharma, Inc. (IGC) | 2025-03-31 | -$0.09 | n/m |
| Vistagen Therapeutics, Inc. (VTGN) | 2026-03-31 | -$1.83 | n/m |
| Longeveron Inc. (LGVN) | 2025-12-31 | -$1.29 | n/m |
| Neuphoria Therapeutics Inc. (NEUP) | 2026-06-30 | -$3.06 | n/m |
| Rani Therapeutics Holdings, Inc. (RANI) | 2025-12-31 | -$0.45 | n/m |
| China SXT Pharmaceuticals, Inc. (SXTC) | 2026-03-31 | -$9.13 | n/m |
Compare NWBO, ATXI, NRXP, IGC side by side · Screen every company in Pharmaceutical Preparations ↗